Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea (2015)
- Authors:
- USP affiliated authors: DRAGER, LUCIANO FERREIRA - FM ; MACHADO, BENEDITO HONÓRIO - FMRP
- Unidades: FM; FMRP
- DOI: 10.1152/ajpheart.00094.2015
- Subjects: ANÓXIA; ARTERIOSCLEROSE (COMPLICAÇÕES;ETIOLOGIA); DOENÇAS CARDIOVASCULARES; APNEIA DO SONO (COMPLICAÇÕES)
- Language: Inglês
- Imprenta:
- Source:
- Título: American journal of physiology. Heart and circulatory physiology
- ISSN: 0363-6135
- Volume/Número/Paginação/Ano: v. 309, n. 7, p. H1101-H1111, 2015
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
DRAGER, Luciano F. et al. Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea. American journal of physiology. Heart and circulatory physiology, v. 309, n. 7, p. H1101-H1111, 2015Tradução . . Disponível em: https://doi.org/10.1152/ajpheart.00094.2015. Acesso em: 23 jan. 2026. -
APA
Drager, L. F., Polotsky, V. Y., O'Donnell, C. P., Cravo, S. L., Lorenzi-Filho, G., & Machado, B. H. (2015). Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea. American journal of physiology. Heart and circulatory physiology, 309( 7), H1101-H1111. doi:10.1152/ajpheart.00094.2015 -
NLM
Drager LF, Polotsky VY, O'Donnell CP, Cravo SL, Lorenzi-Filho G, Machado BH. Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea [Internet]. American journal of physiology. Heart and circulatory physiology. 2015 ; 309( 7): H1101-H1111.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1152/ajpheart.00094.2015 -
Vancouver
Drager LF, Polotsky VY, O'Donnell CP, Cravo SL, Lorenzi-Filho G, Machado BH. Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea [Internet]. American journal of physiology. Heart and circulatory physiology. 2015 ; 309( 7): H1101-H1111.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1152/ajpheart.00094.2015 - Resistant hypertension: time to consider the best fifth anti-hypertensive treatment
- Rationale and methodology of the SARAH Trial: Long-term cardiovascular outcomes in patients with resistant hypertension and obstructive sleep apnea
- Does the RYGB common limb length influence hypertension remission and cardiometabolic risk factors? Data from the GATEWAY trial: data from the GATEWAY trial
- Bariatric Surgery for Resistant Hypertension: Working in Progress!
- OSA and cardiometabolic risk: What's the bottom line?
- Are we missing obstructive sleep apnea diagnosis?[Editorial]
- Apneia Obstrutiva do Sono e Aterosclerose: uma abordagem translacional
- Insomnia episodes, new-onset pharmacological treatments, and other sleep disturbances during the COVID-19 pandemic: a nationwide cross-sectional study in Brazilian health care professionals
- OSA and Prognosis After Acute Cardiogenic Pulmonary Edema The OSA-CARE Study
- Obstructive Sleep Apnea and Diabetes Independently Add to Cardiovascular Risk After Coronary Revascularization [Carta]
Informações sobre o DOI: 10.1152/ajpheart.00094.2015 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
